MCI allows online prescription of Psychiatry medicines including Phenobarbitone, Clobazam and Clonazepam
New Delhi: In the interest of psychiatric patients, the Board of Governors in supersession of the Medical Council of India (MCI BoG) has modified the telemedicine practice guidelines now allowing the doctors to prescribe certain anti-anxiety and sedative drugs used in psychiatry through video-consultation.
The decision to this effect was taken by the MCI BoG's Secretary-General Dr RK Vats considering the current scenario across the country amid the coronavirus outbreak due to which the patients are not able to visit the psychiatrists for consultation and were facing difficulties in getting these anti-anxiety neurological drugs without a doctors prescription.
So far, these drugs such as Phenobarbitone, Clobazam and Clonazepam could only be purchased on a hardcopy prescription by a doctor with his stamp. Now, with the MCI's order, the concerned patients will be able to purchase these medicines on a doctor's online/soft copy prescription.
The notice issued on the same states:
Modification in Medicine list in Telemedicine Practice Guidelines
1. The Board of Governors in Super-session of Medical Council of India in discharge of their special responsibilities prescribed under Guidelines 6.1 of Telemedicine Practice Guidelines make the following modification the in the "Medicine Lists" contained in Annexure-1 of Telemedicine Practice Guidelines.
2. Following Medicines shall be added to list A of Medicine Lists after the existing entries:
Drugs used in Psychiatry practice such as Phenobarbitone, Clobazam and Clonazepam as first consult and as well as follow up.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.